Talat Imran - 07 Nov 2023 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Executive Officer, Director
Signature
/s/ Talat Imran
Issuer symbol
RANI
Transactions as of
07 Nov 2023
Transactions value $
$9,975
Form type
4
Filing time
09 Nov 2023, 16:05:10 UTC
Previous filing
29 Mar 2023
Next filing
01 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RANI Class A Common Stock Purchase $4,950 +2,500 +0.56% $1.98 446,955 07 Nov 2023 Direct F1
transaction RANI Class A Common Stock Purchase $5,025 +2,500 +0.56% $2.01 449,455 07 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.